Patient Engagement: From Awareness to Real Involvement

Strategic communication that activates and supports patients

1About this service

Patient engagement is more than education. It's creating meaningful interactions that help patients understand their treatment, improve adherence, and actively participate in their care process.

At MakeSense Health, we develop patient engagement strategies that combine empathy and intelligence. From diagnosis to chronic disease management: we design communication that truly helps.

Our approach is evidence-based and patient-centric. We use behavioral science, digital tools, and creative storytelling to empower patients without overwhelming them.

2Our patient engagement expertise

  • Patient journey mapping: We understand every phase of the patient journey
  • Behavioral design: Scientifically validated interventions for behavior change
  • Digital platforms: From apps to patient portals and community platforms
  • Adherence programs: Proven effective adherence strategies
  • Empathetic content: Communication that resonates without exaggeration

3From our work

Huidfonds Smeerinstructies

Interactive patient education for eczema treatment

Pfizer Check-Plan-Actie

Helps people recognise their risk and talk to their doctor

4Frequently asked questions

What is the difference between patient engagement and patient education?

Education provides information. Patient engagement goes further: it helps people use that information, for example to recognise their risk, start a conversation with their doctor or stay on their treatment.

May a pharma company approach patients directly?

Advertising prescription medicines to the public is not allowed. Disease awareness, non-branded campaigns and support for patients already on treatment are possible, provided they meet the rules. For each project we determine what fits within the CGR code or the pharma.be code, and the client approves.

Do you involve patients in creating materials?

Wherever possible. We develop materials together with patient organisations, doctors and the audience itself, so that language and format match what people really need.

What happens if someone reports a side effect?

If we come across a possible side effect in our work, we forward it to the client's pharmacovigilance team within one working day. We refer patients to the marketing authorisation holder, to Lareb in the Netherlands or to the FAMHP in Belgium.

Let's discuss your patient engagement strategy

Schedule a meeting View our approach